These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20338809)

  • 1. Neuropathogenesis of human and murine malaria.
    Riley EM; Couper KN; Helmby H; Hafalla JC; de Souza JB; Langhorne J; Jarra WB; Zavala F
    Trends Parasitol; 2010 Jun; 26(6):277-8. PubMed ID: 20338809
    [No Abstract]   [Full Text] [Related]  

  • 2. Murine cerebral malaria: how far from human cerebral malaria?
    Carvalho LJ
    Trends Parasitol; 2010 Jun; 26(6):271-2. PubMed ID: 20335068
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebral malaria: human versus mouse studies.
    Stevenson MM; Gros P; Olivier M; Fortin A; Serghides L
    Trends Parasitol; 2010 Jun; 26(6):274-5. PubMed ID: 20382077
    [No Abstract]   [Full Text] [Related]  

  • 4. Murine cerebral malaria: the whole story.
    Hunt NH; Grau GE; Engwerda C; Barnum SR; van der Heyde H; Hansen DS; Schofield L; Golenser J
    Trends Parasitol; 2010 Jun; 26(6):272-4. PubMed ID: 20382078
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebral malaria: in praise of epistemes.
    Rénia L; Grüner AC; Snounou G
    Trends Parasitol; 2010 Jun; 26(6):275-7. PubMed ID: 20363672
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of animal models for research on severe malaria.
    Craig AG; Grau GE; Janse C; Kazura JW; Milner D; Barnwell JW; Turner G; Langhorne J;
    PLoS Pathog; 2012 Feb; 8(2):e1002401. PubMed ID: 22319438
    [No Abstract]   [Full Text] [Related]  

  • 7. The murine cerebral malaria phenomenon.
    White NJ; Turner GD; Medana IM; Dondorp AM; Day NP
    Trends Parasitol; 2010 Jan; 26(1):11-5. PubMed ID: 19932638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria.
    Amani V; Boubou MI; Pied S; Marussig M; Walliker D; Mazier D; Rénia L
    Infect Immun; 1998 Sep; 66(9):4093-9. PubMed ID: 9712753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Young Sprague Dawley rats infected by Plasmodium berghei: A relevant experimental model to study cerebral malaria.
    Keita Alassane S; Nicolau-Travers ML; Menard S; Andreoletti O; Cambus JP; Gaudre N; Wlodarczyk M; Blanchard N; Berry A; Abbes S; Colongo D; Faye B; Augereau JM; Lacroux C; Iriart X; Benoit-Vical F
    PLoS One; 2017; 12(7):e0181300. PubMed ID: 28742109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular dysfunction as a target for adjuvant therapy in cerebral malaria.
    Carvalho LJ; Moreira Ada S; Daniel-Ribeiro CT; Martins YC
    Mem Inst Oswaldo Cruz; 2014 Aug; 109(5):577-88. PubMed ID: 25185000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antimicrobial molecule trappin-2/elafin has anti-parasitic properties and is protective in vivo in a murine model of cerebral malaria.
    Roussilhon C; Bang G; Bastaert F; Solhonne B; Garcia-Verdugo I; Peronet R; Druilhe P; Sakuntabhai A; Mecheri S; Sallenave JM
    Sci Rep; 2017 Feb; 7():42243. PubMed ID: 28181563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis.
    Nie CQ; Bernard NJ; Schofield L; Hansen DS
    Infect Immun; 2007 May; 75(5):2275-82. PubMed ID: 17325053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine malaria is associated with significant hearing impairment.
    Schmutzhard J; Kositz CH; Lackner P; Dietmann A; Fischer M; Glueckert R; Reindl M; Stephan K; Riechelmann H; Schrott-Fischer A; Schmutzhard E
    Malar J; 2010 Jun; 9():159. PubMed ID: 20540722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA.
    Ding Y; Xu W; Zhou T; Liu T; Zheng H; Fu Y
    Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro model offers insight into the pathophysiology of severe malaria.
    Taylor-Robinson A
    Lancet; 2004 May; 363(9422):1661-3. PubMed ID: 15158624
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebral malaria: a vasculopathy.
    Desruisseaux MS; Machado FS; Weiss LM; Tanowitz HB; Golightly LM
    Am J Pathol; 2010 Mar; 176(3):1075-8. PubMed ID: 20093501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-selectin contributes to severe experimental malaria but is not required for leukocyte adhesion to brain microvasculature.
    Chang WL; Li J; Sun G; Chen HL; Specian RD; Berney SM; Granger DN; van der Heyde HC
    Infect Immun; 2003 Apr; 71(4):1911-8. PubMed ID: 12654808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rocaglates as dual-targeting agents for experimental cerebral malaria.
    Langlais D; Cencic R; Moradin N; Kennedy JM; Ayi K; Brown LE; Crandall I; Tarry MJ; Schmeing M; Kain KC; Porco JA; Pelletier J; Gros P
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2366-E2375. PubMed ID: 29463745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease.
    de Souza JB; Hafalla JC; Riley EM; Couper KN
    Parasitology; 2010 Apr; 137(5):755-72. PubMed ID: 20028608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization against cerebral pathology in Plasmodium berghei-infected mice.
    Curfs JH; Hermsen CC; Meuwissen JH; Eling WM
    Parasitology; 1992 Aug; 105 ( Pt 1)():7-14. PubMed ID: 1437278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.